Pfizer said Monday the vaccine maker plans to submit its experimental Lyme vaccine to the FDA for approval, even though the drug failed to show conclusively that it was effective at preventing the disease. The move elicited skepticism from among even the most staunch supporters of the vaccine industry.
Pfizer Wants FDA To Approve Its Vaccine For Lyme Disease — But Does It Have A Shot?
You May Also Like
Study Links Eczema Severity to Sleep Disruption and Memory Problems
November 12, 2026
Meta Expands AI Age Checks To Detect Suspected Teen Users
November 12, 2026
